Iran plans to stop using the local
Fakhravac
vaccine
against Corona, due to a lack of demand, the country's Department of Defense announced today (Tuesday), according to New York Times reports.
The country's five other local vaccines may be in danger as well - as the Iranians prefer, according to the data, the imported vaccines.
The place of Iranian vaccines has been undermined in the country, following the Ministry of Health's decision to withdraw from its initial promise that it would purchase large quantities of vaccine doses from local manufacturers.
"We are preparing to stop producing the vaccine - because who will we sell it to?"
Ahmad Krimi, director of Fakhravac's immunization program, told Iranian news outlets today.
According to him - about a million doses of the vaccine have already been collected.
A day after the Ministry of Defense announced its plans, the head of the Food and Drug Administration in the country promised to purchase three million doses of Fakhravac, along with another local vaccine.
However, it is still unclear whether this will affect the Ministry of Defense's decision to stop said production.
As you may recall, Iran was among the countries hardest hit by the plague.
The official death toll in the country so far stands at about 125,000 people, but health officials and independent experts believe that the real figure is several times higher.
Fakhravac's vaccine has received emergency approval for use in Iran, and has undergone further clinical trials in order to obtain full approval.
